logo
  

Stock Alert: MyoKardia Surges 60% On Bristol Myers Acquisition

Shares of MyoKardia, Inc. (MYOK) soared nearly 60% on Monday morning after Bristol Myers Squibb (BMY) agreed to buy MyoKardia for $13.1 billion.

MYOK is currently trading at $221.22, up $81.62 or 58.47%, on the Nasdaq.

MyoKardia is a clinical-stage biopharmaceutical company developing targeted therapies for the treatment of serious cardiovascular diseases. Bristol Myers agreed to acquire MyoKardia for $225 per share in cash.

MyoKardia's lead candidate is Mavacamten, which successfully completed a phase III trial in obstructive hypertrophic cardiomyopathy recently. A New Drug Application for Mavacamten in the treatment of obstructive hypertrophic cardiomyopathy is expected to be submitted to the FDA in the first quarter of 2021.

Bristol Myers Squibb expects MyoKardia's acquisition to strengthen and expand its cardiovascular franchise. The deal is expected to close during the fourth quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Omaha, Nebraska- based Greater Omaha Packing is recalling around 295,236 pounds of raw beef products citing the possible presence of E. coli O157:H7, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The raw beef products intended for non-intact use were produced on July 13. Consumer goods giant Procter & Gamble Co. (PG) on Friday reported a four percent increase in profit for the fourth quarter from last year, driven by net sales growth across its operating segments, partially offset by a reduction in operating margin. Both revenue and core earnings per share for the quarter beat analysts' estimates. Looking ahead, the company also initiated outlook for fiscal 2022. While reporting financial results for the second quarter on Friday, Colgate-Palmolive Co. (CL) maintained its earnings, adjusted earnings and sales growth guidance for the full-year 2021. For fiscal 2021, the company now expects earnings per share to grow at the lower end of its low to mid-single-digit...
Follow RTT